Heerka Nadiifinta Kelyaha
Hab-xisaabeedka MDRD (Modification of Diet in Renal Disease)
Natiijada
Heerka Nadiifinta Kelyaha oo la Qiyaasay (eGFR)
Kala Soocidda:
Heerka KDIGO:
Ogaanshaha CKD waxaa loo baahan yahay xumaan joogto ah oo ka badan 3 bilood
Fiiro gaar ah: eGFR > 60 mL/min/1.73 m², MDRD wuxuu u badan yahay inuu hoos u qiyaaso shaqada kelyaha. Ka fiirsii xaqiijinta hab-xisaabeedka CKD-EPI 2021, kaas oo ay ku talinayaan hagayaasha hadda ee heerkan.
Fiiro (KDIGO 2012): eGFR ≥ 60 mL/min/1.73 m² kaligeed kuma ogaan karto CKD. Waxaa loo baahan yahay ugu yaraan hal calaamad oo dheeraad ah oo dhaawaca kelyaha ah (albuminuria, dhiig fitsaaraha glomerular, xanuunka tubular, natiija anatomiga ah, natiija sawir ka soo baxday, ama ku-dhaqan kelyo), oo socda in ka badan 3 bilood.
Kala Soocidda Shaqada Kelyaha — KDIGO 2012
| eGFR (mL/min/1.73 m²) | Kala Soocidda | Heerka |
|---|---|---|
| ≥ 90 | Caadi ama sare | G1 |
| 60 – 89 | Hoos u dhac yar | G2 |
| 45 – 59 | Hoos u dhac yar ilaa dhexdhexaad | G3a |
| 30 – 44 | Hoos u dhac dhexdhexaad ilaa daran | G3b |
| 15 – 29 | Hoos u dhac daran | G4 |
| < 15 | Fashilka kelyaha | G5 |
Ku Saabsan Hab-xisaabeedka MDRD
Hab-xisaabeedka dib loo qeexay (IDMS — heerka hadda)
eGFR = 175 × (Creatinine)^(−1.154) × (Da'da)^(−0.203) × (0.742 haddii dheddig ah) × (1.212 haddii madow ah)
Lambarka 175 waxaa loo isticmaalaa creatinine lagu cabbiray hab IDMS ah (Levey et al., 2006), taasoo ah heerka shaybaaradaha casriga ah. Daabacaaddii 1999-kii asalka ahayd waxay isticmaashay lambarka 186, oo kaliya loo isticmaali karo habka aan IDMS ahayn.
Isticmaalka Caafimaad
Hab-xisaabeedka MDRD waxaa loo soo saaray oo loo hubiyay bukaanada qaba xanuunka kelyaha joogtada ah. Waxay bixisaa eGFR oo horeba loogu habeeyay dhererka jirka caadiga ah ee 1.73 m², iyadoon loo baahnayn miisaanka bukaanka.
Xayiraadaha
MDRD wuxuu u badan yahay inuu hoos u qiyaaso eGFR-ga dadka leh shaqo kelyo oo caadi ah ama ku dhawaad caadi ah (eGFR > 60 mL/min/1.73 m²). Heerkan, hagayaasha hadda ay ku talinayaan hab-xisaabeedka CKD-EPI 2021, kaas oo si fiican u shaqeeya oo aan ku darsanayn isirka qowmiyadda.
Fiiro ku saabsan isirka qowmiyadda
Lambarka isku-dhufashada ee isirka Madow (1.212) waa qayb ka mid ah hab-xisaabeedka MDRD ee la hubiyay. Sanadka 2021, NKF-ASN Task Force waxay ku talisay in la isticmaalo hab-xisaabeedka CKD-EPI 2021 — kaas oo ka saaraya isirka qowmiyadda — inuu noqdo hab-xisaabeedka la doorbido ee qiyaasta eGFR-ga.
Fiiro gaar ah: eGFR kaligeed kuma ogaan karto xanuunka kelyaha joogtada ah. Ogaanshuhu wuxuu u baahan yahay xumaan joogto ah oo ka badan 3 bilood, oo la xiriirta calaamado kale oo dhaawaca kelyaha marka la habboonaado. Kalkuleytarkani kama beddelayo qiimeynta takhasusleyaasha kelyaha.
Tixraacyada
- 1. Levey AS, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461–470. PubMed ↗
- 2. Levey AS, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247–254. PubMed ↗
- 3. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1):1–150. PubMed ↗
- 4. Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737–1749. PubMed ↗